Dimethylheptylpyran
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:DMHP.svg | |
| Dimethylheptylpyran
| |
| Systematic (IUPAC) name | |
| 6,6,9-trimethyl-3-(3-methyloctan-2-yl)-
7,8,9,10-tetrahydrobenzo[c]chromen-1-ol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C25H38O2 |
| Mol. mass | 370.57 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule I / Class A |
| Routes | ? |
Dimethylheptylpyran (DMHP, 1,2-dimethylheptyl-Δ3THC) is a synthetic analogue of THC, which was invented in 1949 during attempts to elucidate the structure of Δ9-THC, the active component of cannabis.[1]
DMHP is similar in both structure to THC, differing only in the position of one double bond, and the replacement of the 3-pentyl chain with a 3-(1,2-dimethylheptyl) chain.[1] It produces similar activity to THC, such as sedative and antinauseant effects,[1] but is considerably more potent.[1] It is thought to act as a CB1 agonist, in a similar manner to other similar cannabinoid derivatives.[1]
DMHP was made illegal under UN convention in 1982 on the basis of its structural similarity and similar effects profile to THC, despite never having had any recorded instances of abuse by humans or illicit sale. In the United States, DMHP was placed into the most restrictive Schedule 1 as a compound with no medical use, although it is still used in some scientific research into cannabinoid drugs.
 | This pharmacology-related article is a stub. You can help WikiDoc by expanding it. |
References
